Premature ovarian insufficiency (POI) severely limits reproductive options. We report a successful live birth in a patient with POI following a combined approach of intraovarian platelet-rich plasma (PRP) treatment, double ovarian stimulation (DuoStim protocol), and preimplantation genetic testing for aneuploidy (PGT-A). PRP treatment was performed to restore ovarian function, after which DuoStim was used to maximize oocyte yield. An embryo obtained underwent PGT-A, and transfer of a euploid blastocyst resulted in an uncomplicated pregnancy and the birth of a healthy child. This case highlights the potential of personalized and multidisciplinary strategies to overcome the traditional barriers in POI by integrating regenerative medicine (PRP), advanced ovarian stimulation (DuoStim), and genetic embryo selection (PGT-A). While this innovative approach appears promising for women with diminished ovarian reserve, further studies are needed to confirm its efficacy and safety.
Successful Pregnancy Following Ovarian Platelet-Rich Plasma (PRP) Treatment, the DuoStim Protocol, and Preimplantation Genetic Testing for Aneuploidy in a Patient With Premature Ovarian Insufficiency: A Case Report / Costanzi, Flavia; Greco, Ermanno; Fusco, Sara; Dani, Gianluca; Grimaldi, Giuseppe; Stigliano, Maria Alba; Listorti, Ilaria; Greco, Pierfrancesco. - In: CUREUS. - ISSN 2168-8184. - 17:12(2025). [10.7759/cureus.98505]
Successful Pregnancy Following Ovarian Platelet-Rich Plasma (PRP) Treatment, the DuoStim Protocol, and Preimplantation Genetic Testing for Aneuploidy in a Patient With Premature Ovarian Insufficiency: A Case Report
Costanzi, Flavia
;Greco, Ermanno;Listorti, Ilaria;Greco, Pierfrancesco
2025
Abstract
Premature ovarian insufficiency (POI) severely limits reproductive options. We report a successful live birth in a patient with POI following a combined approach of intraovarian platelet-rich plasma (PRP) treatment, double ovarian stimulation (DuoStim protocol), and preimplantation genetic testing for aneuploidy (PGT-A). PRP treatment was performed to restore ovarian function, after which DuoStim was used to maximize oocyte yield. An embryo obtained underwent PGT-A, and transfer of a euploid blastocyst resulted in an uncomplicated pregnancy and the birth of a healthy child. This case highlights the potential of personalized and multidisciplinary strategies to overcome the traditional barriers in POI by integrating regenerative medicine (PRP), advanced ovarian stimulation (DuoStim), and genetic embryo selection (PGT-A). While this innovative approach appears promising for women with diminished ovarian reserve, further studies are needed to confirm its efficacy and safety.| File | Dimensione | Formato | |
|---|---|---|---|
|
Costanzi_Successful_2025.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
3.27 MB
Formato
Adobe PDF
|
3.27 MB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


